Cervical cancer (CC) is the fourth leading cause of cancer death (~ 324,000 deaths
annually) among women internationally, with 85% of these deaths reported in developing …

Abstract Treatment failure is one of the main hurdles in treating cervical cancer, despite
significant breakthroughs in both conventional and targeted therapy. The one-year survival …

Cervical cancer remains one of the most common cancers in women around the world
however therapeutic options in the advanced and recurrent setting are limited. Immune …

Cervical cancer is the first identified human papillomavirus (HPV) associated cancer and the
most promising malignancy to be eliminated. However, the ever-changing virus subtypes …

Cervical cancer (CC) caused by human papillomavirus (HPV) is one of the largest causes of
malignancies in women worldwide. Cisplatin is one of the widely used drugs for the …

Cervical cancer ranks as the fourth most common form of cancer worldwide. There is a large
number of situations that may be examined in the developing world. The risk of contracting …

Opinion statement Cervical cancer (CC) is most often caused by the human papillomavirus
(HPV). In principle, these ties to the virus should make HPV tumors a relatively easy target …

Cervical cancer is an international public health crisis, affecting several hundred thousand
women annually. While not universally protective due to other risk factors, many such cases …

Cervical cancer is the second most common gynecological malignant tumor endangering
the health of women worldwide. Despite advances in the therapeutic strategies available to …

Although there has been significant progress in prevention and treatment of cervical cancer,
this malignancy is still a leading cause of cancer death for women. Anti-angiogenesis and …